Next Time Moves It’ll Be a Hike, Says Economist Today
Markets pivot as inflation remains above target and energy prices climb. One economist warns the next time moves it’l...
Which Performs Better Over Time Index Or Active
Compare long-run outcomes for index versus active strategies, emphasizing time horizons, persistence of outperformance, and practical takeaways.
27,723 articles
Intuitive Surgical Dropped This Year: Buy Opportunity?
Intuitive Surgical has faced a sharp stock pullback this year. This article breaks down the factors behind the move, ...
The $20,000 Longevity Weekend Reframes Time as Luxury
Premium wellness retreats priced at $20,000 for four days are fueling a new form of health-focused luxury travel. Thi...
Tech Investor Director Sells: Is It Time to Sell Stocks?
When a tech insider sells a large stake, investors weigh a range of signals. This guide breaks down what the move cou...
Micron Just Something Even: Is It a Buy Opportunity in AI?
As AI drives demand for faster memory, Micron sits at the center of a cyclical industry that can fuel outsized moves....
Down 17%, Netflix After: Is It a Buy Now or Not?
Netflix has cooled off, and rumors about Warner Bros. and Roku fueled debate. This guide analyzes whether the pullbac...
Commercial Metals’ Blowout Quarter Signals Steel Turnaround
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
Bitwise Brings Crypto Model Portfolios to Retail Apps
Bitwise Asset Management will embed crypto model portfolios into Parrot Finance's retail investing app, marking a shi...
Scotiabank Lifts Cameco Target to $175 Amid Nuclear Revival
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
Forget Super Micro Computer: Buy This AI Hardware Stock Now
As AI server demand remains robust, one legacy tech giant stands out as a buy-after-pullback play. This piece weighs ...
Barclays Hikes Atlassian Price Target to $112 on ARR
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status